drugset / Trial / NCT00002565
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
RandomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective for intermediate-grade or immunoblastic non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens in treating patients who have intermediate-grade or immunoblastic non-Hodgkin's lymphoma.
Timeline
- Start
- 1994-05-25
- Primary completion
- 2007-02-05
- Completion
- 2007-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | — | — |
| Subject | Bleomycin | Unknown | — | — |
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Idarubicin | Small molecule | — | — |
| Subject | Ifosfamide | Small molecule | — | — |
| Subject | Methylprednisolone | Other / unclassified | — | — |
| Subject | Mitoxantrone | Small molecule | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Vincristine | Small molecule | — | — |